Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial
- PMID: 22795617
- PMCID: PMC3494746
- DOI: 10.1016/j.psyneuen.2012.06.011
Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial
Abstract
Background: Although yoga and meditation have been used for stress reduction with reported improvement in inflammation, little is known about the biological mechanisms mediating such effects. The present study examined if a yogic meditation might alter the activity of inflammatory and antiviral transcription control pathways that shape immune cell gene expression.
Methods: Forty-five family dementia caregivers were randomized to either Kirtan Kriya Meditation (KKM) or Relaxing Music (RM) listening for 12 min daily for 8 weeks and 39 caregivers completed the study. Genome-wide transcriptional profiles were collected from peripheral blood leukocytes sampled at baseline and 8-week follow-up. Promoter-based bioinformatics analyses tested the hypothesis that observed transcriptional alterations were structured by reduced activity of the pro-inflammatory nuclear factor (NF)-κB family of transcription factors and increased activity of Interferon Response Factors (IRFs; i.e., reversal of patterns previously linked to stress).
Results: In response to KKM treatment, 68 genes were found to be differentially expressed (19 up-regulated, 49 down-regulated) after adjusting for potentially confounded differences in sex, illness burden, and BMI. Up-regulated genes included immunoglobulin-related transcripts. Down-regulated transcripts included pro-inflammatory cytokines and activation-related immediate-early genes. Transcript origin analyses identified plasmacytoid dendritic cells and B lymphocytes as the primary cellular context of these transcriptional alterations (both p<.001). Promoter-based bioinformatic analysis implicated reduced NF-κB signaling and increased activity of IRF1 in structuring those effects (both p<.05).
Conclusion: A brief daily yogic meditation intervention may reverse the pattern of increased NF-κB-related transcription of pro-inflammatory cytokines and decreased IRF1-related transcription of innate antiviral response genes previously observed in healthy individuals confronting a significant life stressor.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflicts of interest:
H.L. received grant funding from the Forest Research Institute and is a consultant to the Lilly and Dey Pharmaceutical Companies.
Figures


Similar articles
-
A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity.Int J Geriatr Psychiatry. 2013 Jan;28(1):57-65. doi: 10.1002/gps.3790. Epub 2012 Mar 11. Int J Geriatr Psychiatry. 2013. PMID: 22407663 Free PMC article. Clinical Trial.
-
Online, low-volume meditation does not alter immune-related biomarkers.Brain Behav Immun Health. 2022 Oct 3;26:100531. doi: 10.1016/j.bbih.2022.100531. eCollection 2022 Dec. Brain Behav Immun Health. 2022. PMID: 36267832 Free PMC article.
-
Nuclear factor kappa-B cell (NF-κB), interferon regulatory Factor, and glucocorticoid receptor pathway activation in major depressive Disorder: The role of cytomegalovirus infection.Brain Behav Immun. 2025 Jan;123:1052-1060. doi: 10.1016/j.bbi.2024.11.017. Epub 2024 Nov 10. Brain Behav Immun. 2025. PMID: 39532200
-
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease.Front Immunol. 2019 May 24;10:1176. doi: 10.3389/fimmu.2019.01176. eCollection 2019. Front Immunol. 2019. PMID: 31178872 Free PMC article. Review.
-
Enhancement of cancer stem cell susceptibility to conventional treatments through complementary yoga therapy: possible cellular and molecular mechanisms.J Stem Cells. 2012;7(4):261-7. J Stem Cells. 2012. PMID: 24196800 Review.
Cited by
-
Nervous system regulation of the cancer genome.Brain Behav Immun. 2013 Mar;30 Suppl(Suppl):S10-8. doi: 10.1016/j.bbi.2012.11.008. Epub 2012 Dec 1. Brain Behav Immun. 2013. PMID: 23207104 Free PMC article. Review.
-
The Effect of Mindfulness-Based Stress Reduction (MBSR) on Depression, Cognition, and Immunity in Mild Cognitive Impairment: A Pilot Feasibility Study.Clin Interv Aging. 2020 Aug 12;15:1365-1381. doi: 10.2147/CIA.S249196. eCollection 2020. Clin Interv Aging. 2020. PMID: 32848377 Free PMC article. Clinical Trial.
-
Tai chi, cellular inflammation, and transcriptome dynamics in breast cancer survivors with insomnia: a randomized controlled trial.J Natl Cancer Inst Monogr. 2014 Nov;2014(50):295-301. doi: 10.1093/jncimonographs/lgu028. J Natl Cancer Inst Monogr. 2014. PMID: 25749595 Free PMC article. Clinical Trial.
-
Understanding the nature of health: New perspectives for medicine and public health. Improved wellbeing at lower costs.F1000Res. 2016 Feb 12;5:167. doi: 10.12688/f1000research.7849.1. eCollection 2016. F1000Res. 2016. PMID: 27134730 Free PMC article.
-
Molecules of Silence: Effects of Meditation on Gene Expression and Epigenetics.Front Psychol. 2020 Aug 11;11:1767. doi: 10.3389/fpsyg.2020.01767. eCollection 2020. Front Psychol. 2020. PMID: 32849047 Free PMC article. Review.
References
-
- Alzheimer’s Research & Prevention Foundation. ARPF 2011 Kirtan Kriya. Retrieved Mar 27, 2012 from http://www.alzheimersprevention.org/kirtan_kriya.htm.
-
- Benson H, Beary JF, Carol MP. The relaxation response. Psychiatry. 1974;37:37–46. - PubMed
-
- Chang BH, Dusek JA, Benson H. Psychobiological changes from relaxation response elicitation: long-term practitioners vs. novices. Psychosomatics. 2011;52:550–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R21 AT003480/AT/NCCIH NIH HHS/United States
- K24 MH086481/MH/NIMH NIH HHS/United States
- AT003480/AT/NCCIH NIH HHS/United States
- M01 RR000865/RR/NCRR NIH HHS/United States
- MH086481/MH/NIMH NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- R01-AG026364/AG/NIA NIH HHS/United States
- T32 MH019925/MH/NIMH NIH HHS/United States
- P30 AG028748/AG/NIA NIH HHS/United States
- R01-AG034588/AG/NIA NIH HHS/United States
- R01 HL079955/HL/NHLBI NIH HHS/United States
- R01 MH077650/MH/NIMH NIH HHS/United States
- R01 AG034588/AG/NIA NIH HHS/United States
- R01-CA119159/CA/NCI NIH HHS/United States
- R01-HL079955/HL/NHLBI NIH HHS/United States
- MH077650/MH/NIMH NIH HHS/United States
- R01 HL095799/HL/NHLBI NIH HHS/United States
- R01 CA116778/CA/NCI NIH HHS/United States
- UL1TR000124/TR/NCATS NIH HHS/United States
- P30-AG028748/AG/NIA NIH HHS/United States
- M01 RR000827/RR/NCRR NIH HHS/United States
- R01 AG026364/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical